Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:AGI-43192;AGI 43192,AGI43192 CAS:2377491-54-6 Purity:99.6% Package:1 mg;1 mL;10 mg;100 mg;25 mg;5 mg;50 mg
|
|
| Pyrido[4,3-d]pyrimidin-7(6H)-one, 8-(4-chlorophenyl)-6-(2-methyl-2H-indazol-5-yl)-2-[(2,2,2-trifluoroethyl)amino]- Basic information |
Product Name: | Pyrido[4,3-d]pyrimidin-7(6H)-one, 8-(4-chlorophenyl)-6-(2-methyl-2H-indazol-5-yl)-2-[(2,2,2-trifluoroethyl)amino]- | Synonyms: | Pyrido[4,3-d]pyrimidin-7(6H)-one, 8-(4-chlorophenyl)-6-(2-methyl-2H-indazol-5-yl)-2-[(2,2,2-trifluoroethyl)amino]-;AGI-43192;AGI 43192,AGI43192;8-(4-Chlorophenyl)-6-(2-methyl-2H-indazol-5-yl)-2-[(2,2,2-trifluoroethyl)amino]pyrido[4,3-d]pyrimidin-7(6H)-one | CAS: | 2377491-54-6 | MF: | C23H16ClF3N6O | MW: | 484.86 | EINECS: | | Product Categories: | | Mol File: | 2377491-54-6.mol | ![Pyrido[4,3-d]pyrimidin-7(6H)-one, 8-(4-chlorophenyl)-6-(2-methyl-2H-indazol-5-yl)-2-[(2,2,2-trifluoroethyl)amino]- Structure](CAS/20210305/GIF/2377491-54-6.gif) |
| Pyrido[4,3-d]pyrimidin-7(6H)-one, 8-(4-chlorophenyl)-6-(2-methyl-2H-indazol-5-yl)-2-[(2,2,2-trifluoroethyl)amino]- Chemical Properties |
Boiling point | 601.1±65.0 °C(Predicted) | density | 1.51±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : 83.33 mg/mL (171.86 mM; ultrasonic and warming and heat to 60°C) | pka | 6.69±0.20(Predicted) | form | Solid | color | Light yellow to yellow |
| Pyrido[4,3-d]pyrimidin-7(6H)-one, 8-(4-chlorophenyl)-6-(2-methyl-2H-indazol-5-yl)-2-[(2,2,2-trifluoroethyl)amino]- Usage And Synthesis |
Biological Activity | AGI-43192 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A). AGI-43192 is a potent, but limited brain-penetrant compound. AGI-43192 has the potential for exploring the effects of SAM modulation in the central nervous system (CNS) and research of cancer disease[1]. | References | [1]. Li M, et al. Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads. J Med Chem. 2022;65(6):4600-4615. |
| Pyrido[4,3-d]pyrimidin-7(6H)-one, 8-(4-chlorophenyl)-6-(2-methyl-2H-indazol-5-yl)-2-[(2,2,2-trifluoroethyl)amino]- Preparation Products And Raw materials |
|